Visco-Supplementation Introduction
Visco supplementation is a treatment for osteoarthritis.
Under visco supplementation treatment for arthritis, a hyaluronic acid is injected into the knee joint of the patient. This is a thick fluid infused into the joints of victim that helps reduce pain and swelling in the joints; most commonly knee joint.
The swelling and tenderness of one or more joints are the primary symptoms of arthritis. Joint pain, stiffness of bones etc. are some more signs of the ailment. There are mainly two kinds of joint pains; one is osteoarthritis and another rheumatoid.
Osteoarthritis – causes cartilage (a delicate and dangerous tissue) covering the closures of bones where they structure a joint to break.
Rheumatoid – a disease in which your immune system attacks joints, starting from the lining of the joints.
The most common types of arthritis ailments include tremendous pain, stiffness of bones, swelling, redness etc. Arthritis causes damage to the joints cartilage (a hard, slick coating at the end of bones). Cartilage serves as a cushion at bone end making the joint motion frictionless. Higher damage can result into bone grinding which is very painful and it restricts the movements. The arthritis disease process can eventually damage cartilage and bone within the joint. Under severe cases, the disease affects hands, arms, fingers, even eye lids, and makes it difficult to perform daily tasks. For arthritis there is no complete cure; however, with certain treatments and surgeries, the pain can be reduced. Visco supplementation is one such treatment for arthritis.
Global Visco-Supplementation Market Overview: Forecast, Trend, Growth:
The Global Visco-Supplementation Market was estimated at 3,675 million US dollars in the year 2020 and is projected to display a gain of 8,941 million US dollars in the year 2030 with a CAGR of 9.4% for the duration of 2021-2030.
Download Sample copy of Visco-Supplementation Market Research Report
As per the 2017 reports by GBD (Global Burden of Diseases, Injuries, and Risk Factors), approximately 19 lakh cases were prevalent with RA globally, with a prevalence rate of 246 cases over 1 lakh population. This ratio increased to 7.4% between 1990 to 2017. The rate of rising patients is fuelling the market.
Since past few years, there have been huge changes in medical technology. With this rise, demand for non-surgical treatments, and in addition, life-style induced disorders are also ascending. Besides all these factors, one of the prominent reason is rise in geriatric population. Few more aspects which are fuelling the market include rise in obesity, unhealthy food habits, lack of physical exertion, rise in sedentary jobs, desk jobs for long hours etc.
According to Arthritis establishment over 130 million individuals across the globe are impacted by osteoarthritis. The success rate of alleviating the pain in Visco-Supplementation is 86% for osteoarthritis patients which is creating a positive impact on the market.
Ambulatory Surgical Centres display remunerative opportunity for Visco-Supplementation Market. Ambulatory Surgical Centre is a facility that is a part of any hospital or is known as modern health care facilities provider. These providers focus on giving same-day treatment or surgical care that includes diagnostic and preventive procedures under the guidance of licenced physicians. It has been observed that millions of Americans have been benefited with this more convenient substitute for hospitals.
Over the past few years the therapy of different ongoing sicknesses has been progressively focused on the global health care services and state run administrations; equally in low to medium income nations. As a result of which there has been cogent rise in demand for proper treatment and cure. This has also affected the demand for visco-supplementation as a treatment for osteoarthritis.
With the advancement in technology and value-based care, there has been huge competition within hospitals and health care systems, peculiarly with personal consultations and introduction of ambulatory surgical centres. Due to this competition, the market is expected to rise to a significant level in the coming future.
Global Visco-Supplementation Market Drivers:
Growing geriatric population is the key driving factor of global visco-supplementation market. According to the reports by National Institute of Health there are about 600 million people aged 65 and above worldwide that is relatively 8.5% of the total population. Hence, as per the reports, more population is expected to require visco-supplementation due to various reasons.
Another benefit of visco-supplementation is that it is a cost effective procedure in comparison to knee replacement. Thus, visco-supplementation is expected to be on high demand. This is one of the factor to fuel the market.
Increased awareness on availability of novel treatment and drugs twining with presence of major companies selling it, is propelling the growth of market.
Covid-19 impact on the market:
The recent pandemic has had a catastrophic effect on businesses round the globe. The first wave of Covid-19 had put an immediate halt on overall logistics, including medical appliances. Covid-19 pandemic was the most devastating global public health emergency which has had a long term impact on the market.
The visco-supplementation market was negatively impacted. Due to concurrent lockdown, senior citizens were forced to remain at home as a result of infection. Mass end of elective surgeries in medical clinics drove down the sales of visco-supplementation market.
However, post Covid- 19 restrictions, the market is expected to recover from the deficit, for instance, by the end of June 2020, there was a rise in surgeries in some regions of US, Germany, and Australia.
Global Visco-Supplementation Market Segmentation
Global Visco-Supplementation is segmented into product type, application, source, distribution channel
Market Segmentation by Product type
The Global Visco-Supplementation is further sub-categorised by Product into Single Injection, Three Injections, Five Injections. Visco-Supplementation is usually referred after all other options have been tried and tested and still have no relief. An individual requires to be treated three to five times after every 1 week’s interval. The three injections segment is likely to dominate the market for the forecasted period.
Global Visco-Supplementation Market Segmentation by application
The Global Visco-Supplementation is further sub-categorised by application as
• Knee Osteoarthritis: is a type of Osteoarthritis which is a degenerative joint disease of knee typically a result of wear and tear and progressive loss of articular cartilage. This most common sufferers are geriatric population.
• Hip Osteoarthritis: This Osteoarthritis mainly associated with hip joint generally in groin area. The pain in Hip Osteoarthritis develops slowly and aggravates overtime. The common patients for this type is aged individuals.
• Hand Osteoarthritis: Hand Osteoarthritis is inflammation that causes pain, stiffness and swelling of hand joints mostly at the base of thumb or on one of the joints on fingertips, or middle joint of a finger.
• Shoulder osteoarthritis: It is a gradual wear and tear of articular cartilage that results into pain, stiffness and swelling of shoulder joints. As the joint surface ruffians, the subchondral bone redesigns, trailing its sphericity and congruity.
• Ankle osteoarthritis: Ankle osteoarthritis is depletion of articular cartilage of ankle joints.
The Knee Osteoarthritis displays growth under this section.
Global Visco-Supplementation Market Segmentation by Source
The Global Visco-Supplementation is further sub-categorised by source as Animal and Non-animal, where the Non-animal segment is likely to hit the market in comparison to Animal.
Global Visco-Supplementation Market Segmentation by distribution channel
Based on the distribution channel the market is divided three categories like
• Retail Pharmacies
• Ambulatory Surgical Center’s
• Hospital Pharmacies
• Online Pharmacies
Under this segmentation the retail pharmacies segment dominated the market in 2018 and is projected to grow with significant rate.
Click Here to Direct Purchase Visco-Supplementation Market Research Report
Global Visco-Supplementation Market Top Key Players
Sanofi-Aventis, Anika Therapeutics, Inc., Zimmer Biomet, Chugai Pharmaceutical Co., Ltd are the leading market players that hold majority market share. Apart from the leading players the global Visco-Supplementation participants include following
Alkem Laboratories
Fidia Farmaceutici S.p.A
TRB Chemedica
Seikagaku Corporation
Ferring B.V
Zimmer Biomet
Bharat Biotech
LG Life Sciences
Johnson & Johnson
Cigna
Teva Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories Ltd.
Bioventus Inc.
Viatris Inc
Virchow Biotech
OrthogenRx
APTISSEN
Global Visco-Supplementation Market Regional Outlook
Based on region, Asia-Pacific is likely to display high growth rate in the coming future. The rise is on account of awareness in novel health care facilities and healthcare expenditure. In addition to this, economical manufacturing costs in China and India resulted in rise in production, attracting pharmaceutical and biotechnological giants to Asia- Pacific region. The regional segment accentuates present and future demand for Visco-Supplementation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Contact Us
Credible Markets Analytics
99 Wall Street 2124 New York, NY 10005
Email: sales@crediblemarkets.com
